Phosphorylation of plectin by Akt3 promotes triple-negative breast cancer cell invasive migration

Shixue Zheng1,2, Chloe Chan1, John M Asara3

  • 1Tung Biomedical Sciences Centre and Department of Biomedical Sciences, College of Biomedicine, City University of Hong Kong, Kowloon, Hong Kong.

Iscience
|October 13, 2025
PubMed

Insights

Researchers identified a new signaling pathway involving Akt3 and plectin that drives triple-negative breast cancer (TNBC) growth and metastasis. Targeting this Akt3-plectin interaction may offer a novel therapeutic strategy for aggressive TNBC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies.
  • The PI3K/Akt pathway is crucial in cancer, but isoform-specific roles, especially for Akt3, remain unclear.
  • Akt3 is overexpressed in TNBC and linked to tumor progression.

Purpose of the Study:

  • To investigate the role of Akt3 in TNBC.
  • To identify Akt3 targets in TNBC cells.
  • To explore the therapeutic potential of targeting the Akt3 pathway in TNBC.

Main Methods:

  • Genome-wide proteomic screening to identify Akt3 substrates.
  • Functional assays to assess the impact of plectin depletion on TNBC cells.
  • Analysis of plectin phosphorylation and its effect on cell migration and invadopodia.

Main Results:

  • Plectin identified as an Akt3 substrate in TNBC.
  • Plectin depletion inhibits TNBC cell migration and invadopodia formation.
  • Akt3-mediated phosphorylation of plectin promotes TNBC cell migration via vimentin.

Conclusions:

  • Akt3 plays a significant role in promoting TNBC growth, stemness, and epithelial-mesenchymal transition.
  • The Akt3-plectin signaling axis is critical for TNBC cell migration and invadopodia formation.
  • Targeting Akt3-plectin signaling represents a promising therapeutic strategy for TNBC.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.3K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.2K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
12.0K